Target Global

Target Global is a European multi-stage technology investment firm with offices in Berlin, London, and other locations, investing across software, marketplaces, financial services, and adjacent technology themes from seed through growth. The firm has been an active early-stage investor in European technology, with check sizes scaling by stage from low single-digit millions at Series A to commitments of fifteen to forty million euros or more in growth rounds, with reserves and selective lead capability. Healthcare appears in the portfolio opportunistically rather than as a dedicated vertical, and the firm’s strength is in marketplaces, fintech, and consumer-facing software rather than regulated healthcare. Healthcare AI founders should approach only if the company is fundamentally a software business with breakout commercial dynamics, and a healthcare angle layered on top, rather than a regulated therapeutic, device, or hospital-enterprise-only business. The natural fit is a Series A or growth-stage European or globally-active software company with strong unit economics, ambitious growth trajectory, and the kind of metrics that justify a major European generalist investor’s attention. Founders pursuing capital-intensive therapeutics, complex devices, or deeply regulated healthcare businesses will not match. The best entry path is a warm introduction from a portfolio CEO, a fellow generalist investor, or a European technology banker. Direct outreach via the website or LinkedIn to partners is acceptable for cold contact when the metrics warrant, paired with a tight executive summary and clear growth signals.